Wednesday, December 3, 2025

Minister McEntee speaks with UK Foreign Secretary Cooper

Minister for Foreign Affairs and Trade, Helen McEntee TD, spoke by phone today with the United Kingdom’s Secretary of State for Foreign, Commonwealth and Development Affairs, Yvette Cooper.

Their introductory call focused on the shared ambition of both Governments to deepen cooperation across all aspects of the British-Irish relationship, as committed to at the first UK-Ireland Summit held in March 2025. As well as bilateral relations, Minister McEntee and

Department of Education and Youth and the Teaching Council launch landmark research study on teaching in Ireland

Teachers’ Professional Journeys: The First Decade is a groundbreaking longitudinal research study that is being launched today (3 December 2025).

The study has been jointly commissioned by the Department of Education and Youth and the Teaching Council and was jointly announced in April 2024. Since then, literature review, and research design stages have been completed.

The study is being officially launched today, in advance of the data collection stage which is

Minister Calleary welcomes approval of 2026 funding for Foras na Gaeilge and the Ulster-Scots Agency

  • North South Ministerial Council meeting at Monaghan Peace Campus today
  • €20 million joint funding approved for Foras na Gaeilge and Ulster-Scots Agency
  • Over €2 million additional funding for Foras na Gaeilge programmes and activities
  • €200,000 additional funding for Ulster-Scots activities in the border counties
  • Budget for Clár na Leabhar Gaeilge increases to €2m in 2026

The Minister for Rural and Community Development and the Gaeltacht, Dara Calleary TD, today attended the 30th Sectoral meeting of the North South Ministerial Council (NSMC) Language Body. The meeting, held at Monaghan Peace Campus, was chaired by Gordon

Corporation tax strong to end-November, alongside continued investment in public services and infrastructure – Tánaiste Simon Harris & Minister Jack Chambers

  • Tax revenues to end-November amounted to €97 billion, up by €7.3 billion (8.2 per cent), relative to the same period last year.
  • Of this:
    • Income tax receipts amounted to €33.7 billion, up by €1.5 billion (4.6 per cent);
    • Corporation tax receipts of €29.4 billion are up by €3.8 billion (14.9 per cent);
    • VAT receipts of €22.5 billion were €1.1 billion (5.0 per cent) higher.
  • Total gross voted expenditure to end-November amounted to €97.3 billion, €5.2 billion (5.7 per cent) ahead of the same period last year and just €0.4 billion (0.4 per cent) ahead of profile;
  • An (underlying) Exchequer surplus of €7.1 billion was recorded in November, an improvement of €2.8 billion on last year.
  • Accompanying today’s release, the Tánaiste is publishing an analytical paper prepared by his Department, entitled ‘Fiscal Vulnerabilities: expanding costs, narrowing base’; the paper documents recent developments and risks to Ireland’s public finances arising from the concentrated nature of key revenue streams.

November is the single most important month of the year for tax collection.

Underlying tax revenues amounted to €97.0 billion in the year to end-November, a €7.3

Althera Laboratories and Tabuk Pharmaceuticals Announce Strategic Partnership for Advanced T2D Therapy in MENA

Advanced combination therapy in cardio and metabolic

Logo Althera

Partnership leverages Tabuk’s extensive regional leadership to broaden access to Althera’s innovative Type 2 Diabetes combination therapy

We are delighted to partner with a true leader across the region. This agreement is a significant step in our mission to make innovative, high-value therapies accessible to patients globally.”
— Sanjeev Agarwal, Althera’s CEO

DUBLIN, DUBLIN, IRELAND, December 3, 2025 /EINPresswire.com/ -- Althera Laboratories Limited, a global pharmaceutical company focused on developing value-added cardiovascular and metabolic medicines, and Tabuk Pharmaceuticals, a leading pharmaceutical company in the Middle East and Africa (MENA), today announced a strategic licensing and supply agreement.

The agreement grants Tabuk Pharmaceuticals rights to register and commercialize Althera’s

Zeus Group Appoints Brian O’Kelly and Paul Hogan as Non-Executive Directors

Zeus Building

Zeus Group today announces the appointments of Brian O’Kelly and Paul Hogan as Non-Executive Directors of its Board.

DUBLIN, IRELAND, December 1, 2025 /EINPresswire.com/ -- Zeus Group, a global provider of innovative packaging solutions, today announces the appointments of Brian O’Kelly and Paul Hogan as Non-Executive Directors of its Board. The additions strengthen the company’s governance and

Better, Cheaper, Greener: SSPC honour UL team for groundbreaking chemistry

Associate Professor Soumya Mukherjee, Professor Mike Zawototko, and Associate Professor Matthias Vandichel, University of Limerick, SSPC, Research Ireland Centre for Pharmaceuticals Academic Collaboration Award winners.

The Kyoto collaboration story

Teamwork is always a rewarding and effective way to conduct research but, when one wants to address the most urgent global challenges, it is a prerequisite.”
— Professor Mike Zaworotko

LIMERICK, IRELAND, December 3, 2025 /EINPresswire.com/ -- : Professor Michael Zaworotko, Associate Professor Soumya Mukherjee, and Associate Professor Matthias Vandichel, Department of Chemical Science, and Bernal Institute, University of Limerick

Popular Articles